The Company was formed in 2013 and has secured about 18 m€ of funding with investors including European Innovation Council, Business Finland, Lifeline Ventures and Finnish private investors.
About 50% of our funding is private equity and the other 50% includes grants and long-term government loans from the European Commission and Business Finland. In addition to our founder, TILT’s owners include Lifeline Ventures and several business angels.
The latest equity investment round of 4.5 m€ was completed in May 2020.
Furthermore, the Company has significant revenue through its collaboration and licensing agreement with Biotheus.